Bax cleavage implicates caspase-dependent H2O2-induced apoptosis of hepatocytes. 2003

Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
Department of Surgery II, Graduate School of Biochemical Sciences, Nagasaki University, Nagasaki 852-8501, Japan.

Oxidative stress plays an important role in the development of ischemia/reperfusion (I/R)-induced apoptosis of hepatocytes. We aimed to examine the involvement of caspases and calpains in H2O2-induced hepatic cell apoptosis. TUNEL-positive apoptotic cells appeared in parallel with poly(ADP-ribose) polymerase (PARP) cleavage and procaspase-3 proteolysis by H2O2 treatment in a dose-dependent manner (250-1,000 micro M). Bcl-xL and intact Bax expression levels decreased when H2O2 was >250 micro M. The cleaved form of Bax appeared prior to caspase-3 activation, increasing in a dose-dependent manner. A pan-caspase inhibitor, Z-VAD-fmk, completely blocked H2O2-induced procaspase-3 proteolysis and PARP cleavage without changing Bax cleavage, but partially attenuated H2O2-induced apoptosis. Calpeptin, a calpain inhibitor, did not inhibit caspase-3 activation, Bax cleavage or apoptosis. Our results indicate that Bax cleavage is upstream signal of caspase-dependent apoptosis in hepatocytes exposed to H2O2, but not independent upon calpain. Molecular targeting of Bax cleavage may allow the development of strategies to prevent hepatic I/R injury.

UI MeSH Term Description Entries
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002154 Calpain Cysteine proteinase found in many tissues. Hydrolyzes a variety of endogenous proteins including NEUROPEPTIDES; CYTOSKELETAL PROTEINS; proteins from SMOOTH MUSCLE; CARDIAC MUSCLE; liver; platelets; and erythrocytes. Two subclasses having high and low calcium sensitivity are known. Removes Z-discs and M-lines from myofibrils. Activates phosphorylase kinase and cyclic nucleotide-independent protein kinase. This enzyme was formerly listed as EC 3.4.22.4. Calcium-Activated Neutral Protease,Calcium-Dependent Neutral Proteinase,Ca2+-Activated Protease,Calcium-Activated Neutral Proteinase,Calcium-Activated Protease,Calcium-Dependent Neutral Protease,Calpain I,Calpain II,Desminase,Ca2+ Activated Protease,Calcium Activated Neutral Protease,Calcium Activated Neutral Proteinase,Calcium Activated Protease,Calcium Dependent Neutral Protease,Calcium Dependent Neutral Proteinase,Neutral Protease, Calcium-Activated,Neutral Protease, Calcium-Dependent,Neutral Proteinase, Calcium-Activated,Neutral Proteinase, Calcium-Dependent,Protease, Ca2+-Activated,Protease, Calcium-Activated,Protease, Calcium-Activated Neutral,Protease, Calcium-Dependent Neutral,Proteinase, Calcium-Activated Neutral,Proteinase, Calcium-Dependent Neutral
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004792 Enzyme Precursors Physiologically inactive substances that can be converted to active enzymes. Enzyme Precursor,Proenzyme,Proenzymes,Zymogen,Zymogens,Precursor, Enzyme,Precursors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen

Related Publications

Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
February 2008, Apoptosis : an international journal on programmed cell death,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
January 2009, The Journal of biological chemistry,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
January 2000, Neoplasia (New York, N.Y.),
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
October 1997, Oncogene,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
November 2018, Cell reports,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
June 2019, Ecotoxicology and environmental safety,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
April 2003, Molecular and cellular biology,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
December 2006, Toxicology in vitro : an international journal published in association with BIBRA,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
September 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Hiroaki Tamura, and Akira Ohtsuru, and Yukio Kamohara, and Hikaru Fujioka, and Katsuhiko Yanaga, and Takashi Kanematsu, and Shunichi Yamashita
July 2005, Cancer research,
Copied contents to your clipboard!